Venrock partners Andrew Gottesdiener and Nimish Shah speak with Michael Henderson, CEO of Apogee Therapeutics, about his role’s unique challenges and opportunities. Henderson discusses his accelerated career trajectory, valuable lessons that have helped shape his success, and Apogee’s recent Series B financing round. Henderson delves into the importance of culture building, including Apogee’s guiding principles (CORE: Care, Original, Resilient, Ego-Less), and his strategies for navigating a challenging biotech industry.
